Search research articles
Contact Us
Filters
Showing results (41-50 of 200) with videos related to
Page
of 20
Sort By:
The American Journal of Cardiology
|
December 31, 1997
The treatment gap in coronary artery disease and heart failure: community standards and the post-discharge patient
T A Pearson, T D Peters
Cleveland Clinic Journal of Medicine
|
July 21, 2000
Lowering LDL in patients with heart disease: how aggressive should you be?
T A Pearson, F J Pashkow
Annals of Internal Medicine
|
October 1, 1993
The quest for a cholesterol-decreasing diet: should we subtract, substitute, or supplement?
T A Pearson, R V Patel
Cardiology Clinics
|
February 1, 1996
Lipid lowering: the case for identifying and treating the high-risk patient
T A Pearson, H J Swan
American Journal of Epidemiology
|
May 1, 1987
The association of risk factors with arteriographically defined coronary artery disease: what is the appropriate control group?
L P Fried, T A Pearson
American Journal of Preventive Medicine
|
January 4, 2001
Screening family members at high risk for coronary disease. Why isn't it done?
J R Swanson, T A Pearson
Journal of the American Dietetic Association
|
February 24, 2001
Over-the-counter statin medications: emerging opportunities for RDs.
P Kris-Etherton, T A Pearson
The Canadian Journal of Cardiology
|
June 17, 1998
LDL-cholesterol: a risk factor for coronary artery disease--from epidemiology to clinical trials
R M Werner, T A Pearson
JAMA
|
January 24, 1998
What's so passive about passive smoking? Secondhand smoke as a cause of atherosclerotic disease
R M Werner, T A Pearson
The American Journal of Cardiology
|
May 26, 2001
The imperative to raise low levels of high-density lipoprotein in cholesterol--a better clinical strategy in the prevention and treatment of coronary artery disease. Introduction
T A Pearson, W E Boden
Page
of 20
Search research articles
Search
Showing results (41-50 of 200) with videos related to
Sort By:
Page
of 20
The American Journal of Cardiology
|
December 31, 1997
The treatment gap in coronary artery disease and heart failure: community standards and the post-discharge patient
T A Pearson, T D Peters
Cleveland Clinic Journal of Medicine
|
July 21, 2000
Lowering LDL in patients with heart disease: how aggressive should you be?
T A Pearson, F J Pashkow
Annals of Internal Medicine
|
October 1, 1993
The quest for a cholesterol-decreasing diet: should we subtract, substitute, or supplement?
T A Pearson, R V Patel
Cardiology Clinics
|
February 1, 1996
Lipid lowering: the case for identifying and treating the high-risk patient
T A Pearson, H J Swan
American Journal of Epidemiology
|
May 1, 1987
The association of risk factors with arteriographically defined coronary artery disease: what is the appropriate control group?
L P Fried, T A Pearson
American Journal of Preventive Medicine
|
January 4, 2001
Screening family members at high risk for coronary disease. Why isn't it done?
J R Swanson, T A Pearson
Journal of the American Dietetic Association
|
February 24, 2001
Over-the-counter statin medications: emerging opportunities for RDs.
P Kris-Etherton, T A Pearson
The Canadian Journal of Cardiology
|
June 17, 1998
LDL-cholesterol: a risk factor for coronary artery disease--from epidemiology to clinical trials
R M Werner, T A Pearson
JAMA
|
January 24, 1998
What's so passive about passive smoking? Secondhand smoke as a cause of atherosclerotic disease
R M Werner, T A Pearson
The American Journal of Cardiology
|
May 26, 2001
The imperative to raise low levels of high-density lipoprotein in cholesterol--a better clinical strategy in the prevention and treatment of coronary artery disease. Introduction
T A Pearson, W E Boden
Page
of 20